Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03103932
NA

Biomarker Guided Discharge of Heart Failure Patients

Sponsor: Ottawa Heart Institute Research Corporation

View on ClinicalTrials.gov

Summary

This is a multi-centre, single blind, randomized study. Patients admitted to hospital with acute decompensated heart failure will be randomized to biomarker guided discharge algorithm vs usual care in a 2:1 ratio. NTproBNP and other biomarkers will be measured within 24 hours of admission. The NTproBNP results will be used to further stratify participants randomized to the biomarker guided group into lower and medium to higher risk pathways. Biomarkers will be repeated after 2-3 days and again prior to discharge. Specific care pathways will be followed for each of the lower risk and medium-higher risk groups. Biomarkers will be repeated 30 days post discharge. Participants will be followed with a phone call at 3 months and return for a follow up visit at 6 months post discharge for outcome evaluation.

Official title: BiomarkeR cAndidates to Guide Discharge of Patients Admitted to Hospital With heARt Failure

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

750

Start Date

2017-08-26

Completion Date

2026-12-30

Last Updated

2026-05-06

Healthy Volunteers

No

Interventions

OTHER

Biomarker guided discharge algorithm

participants randomized to the biomarker guided discharge algorithm will follow a pre-determined care pathway for treatment of heart failure symptoms based on admission NTproBNP levels

Locations (1)

University of Ottawa Heart Institute

Ottawa, Ontario, Canada